Abstract

Naproxen 25 mg/mL in Oral Mix or Oral Mix SF

Author(s): Allen Loyd V Jr

Issue: Jan/Feb 2018 - Volume 22, Number 1

Page(s): 54

Download in electronic PDF format for $75
  • Naproxen 25 mg/mL in Oral Mix or Oral Mix SF Page 1

Abstract

A formulation for preparing Naproxen 25 mg/mL in Oral Mix or Oral Mix SF. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

  • naproxen
  • formulation
  • nonsteroidal anti-inflammatory drug
  • NSAID
  • pain relief
  • pain control
  • analgesic
  • analgesia
  • fever
  • migraine headache

Related Categories

  • EXCIPIENTS
  • FORMULATIONS
  • PAIN MANAGEMENT
  • ALLERGY/IMMUNOLOGY/INFLAMMATION

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Jan/Feb 2018
Pg. 54
Naproxen 25 mg/mL in Oral Mix or Oral Mix SF
Author(s): Allen Loyd V Jr
May/Jun 2014
Pg. 239
Naproxen 25-mg/mL Oral Suspension
Author(s): Allen Loyd V Jr
Mar/Apr 2022
Pg. 145
Naproxen 25 mg/mL in SyrSpend SF pH4
Author(s): Allen Loyd V Jr
Sep/Oct 2016
Pg. 410
Naproxen 5% Cream
Author(s): Allen Loyd V Jr
Nov/Dec 2021
Pg. 505
Pyridoxine Hydrochloride 25 mg/mL in Oral Mix and Oral Mix SF Suspension
Author(s): Allen Loyd V Jr
Mar/Apr 2024
Pg. 100-109
Compounded Pain Formulations: What is the Evidence?
Author(s): Asbill Scott, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso
Jul/Aug 2014
Pg. 278-286
Compounded Pain Formulations: What is the Evidence?
Author(s): Asbill Scott, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso
May/Jun 2010
Pg. 182-192
Compounded Analgesic Therapy for Disorders of Movement: Arthritis, Neuropathic Pain, and Postpolio Syndrome
Author(s): Brown Scott, Erickson Brian, Muller George, Bryant-Snure Susan J, Mestayer Richard F III
Mar/Apr 2004
Pg. 101-105
Pluronic Lecithin Organogel for Local Delivery of Anti-Inflammatory Drugs
Author(s): Frankum James, Ramsay Dale, Das Nandita G, Das Sudip K
Mar/Apr 2016
Pg. 155-158
Utilization of Compounded Medications in an Oral Medicine Practice
Author(s): Stock Shannon, Rubino Katie, Woo Sook-Bon, Margolis Arthur, Thomas Irena, Aboalela Ali, Treister Nathaniel
Sep/Oct 2021
Pg. 416
Dexamethasone 1-mg/mL in Oral Mix or Oral Mix SF Suspension
Author(s): Allen Loyd V Jr
Nov/Dec 2017
Pg. 494
Hydroxychloroquine Sulfate 25 mg/mL in Oral Mix or Oral Mix SF
Author(s): Allen Loyd V Jr
May/Jun 2018
Pg. 235
Gabapentin 100 mg/mL in Oral Mix or Oral Mix SF Suspension
Author(s): Allen Loyd V Jr
May/Jun 2004
Pg. 181-185
Compounding in the Pharmacy Curriculum: Beyond the Basics
Author(s): Hinkle Amanda R, Newton Gail D
May/Jun 2010
Pg. 200-203
Topical Medications for Orofacial Neuropathic Pain
Author(s): Bramwell Bethany L
Jan/Feb 2021
Pg. 47
Metronidazole 50-mg/mL in Oral Mix and Oral Mix SF Suspension
Author(s): Allen Loyd V Jr
Jan/Feb 2021
Pg. 44
Clonidine 0.01-mg/mL in Oral Mix and Oral Mix SF Suspension
Author(s): Allen Loyd V Jr
Sep/Oct 2021
Pg. 415
Dapsone 2-mg/mL in Oral Mix or Oral Mix SF Suspension
Author(s): Allen Loyd V Jr
May/Jun 2007
Pg. 200
Case Report: Ketoprofen/Riboflavin/Caffeine Capsules and Progesterone Therapy for Recurrent Migraine Pain
Author(s): Fields Shannon W
Nov/Dec 1999
Pg. 496-500
Enhancement of Skin Penetration of Nonsteroidal Anti-Inflammatory Drugs from Extemporaneously Compounded Topical-Gel Formulations
Author(s): Goodwin Donald A, Fuhram L Clifton